Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individual Patient Access to AbbVie ABT-450/r + ABT-267 and ABT-333
2014-004111-37Phase 3Completed
- Sponsor
- Budai Hepatológiai Centrum
- Start
- Sep 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of paritaprevir, ritonavir, glecaprevir and dasabuvir in hepatitis C virus infection, sponsored by Budai Hepatológiai Centrum. Started Sep 2014; status: completed.
02
Drugs
paritaprevirritonavirglecaprevirdasabuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2014-004111-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004111-37.